BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34634466)

  • 1. Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1.
    Kurz E; Chen S; Vucic E; Baptiste G; Loomis C; Agrawal P; Hajdu C; Bar-Sagi D; Mahal LK
    Mol Cell Proteomics; 2021; 20():100160. PubMed ID: 34634466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.
    Bhalerao N; Chakraborty A; Marciel MP; Hwang J; Britain CM; Silva AD; Eltoum IE; Jones RB; Alexander KL; Smythies LE; Smith PD; Crossman DK; Crowley MR; Shin B; Harrington LE; Yan Z; Bethea MM; Hunter CS; Klug CA; Buchsbaum DJ; Bellis SL
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37643018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes.
    Ohmi Y; Nishikaze T; Kitaura Y; Ito T; Yamamoto S; Sugiyama F; Matsuyama M; Takahashi Y; Takeda A; Kawahara T; Okajima T; Furukawa K; Furukawa K
    Glycobiology; 2021 Jun; 31(5):557-570. PubMed ID: 33242079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
    Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
    Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
    McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
    Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
    Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
    Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.
    Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R
    Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.
    Chakraborty A; Dorsett KA; Trummell HQ; Yang ES; Oliver PG; Bonner JA; Buchsbaum DJ; Bellis SL
    J Biol Chem; 2018 Jan; 293(3):984-994. PubMed ID: 29191829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
    Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
    J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
    Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
    J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.
    Hedlund M; Ng E; Varki A; Varki NM
    Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
    Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
    Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
    Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
    J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tumor cell sialylation in pancreatic cancer progression.
    Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
    Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the CMP-Sialic Acid Donor Specificity of Two Human β-d-Galactoside Sialyltransferases (ST3Gal I and ST6Gal I) Selectively Acting on O- and N-Glycosylproteins.
    Noel M; Gilormini PA; Cogez V; Yamakawa N; Vicogne D; Lion C; Biot C; Guérardel Y; Harduin-Lepers A
    Chembiochem; 2017 Jul; 18(13):1251-1259. PubMed ID: 28395125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST6GAL1: A key player in cancer.
    Garnham R; Scott E; Livermore KE; Munkley J
    Oncol Lett; 2019 Aug; 18(2):983-989. PubMed ID: 31423157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
    Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
    J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.